Details of the Drug

General Information of Drug (ID: DM3ORVD)

Drug Name
Neramexane
Synonyms Neramexane [INN]; Mrz 2579; MRZ 2-579; 1,3,3,5,5-Pentamethylcyclohexanamine; 1,3,3,5,5-pentamethylcyclohexan-1-amine
Indication
Disease Entry ICD 11 Status REF
Cancer related pain MG30 Phase 2 [1]
Therapeutic Class
Analgesics
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 169.31
Logarithm of the Partition Coefficient (xlogp) 2.9
Rotatable Bond Count (rotbonds) 0
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 1
Chemical Identifiers
Formula
C11H23N
IUPAC Name
1,3,3,5,5-pentamethylcyclohexan-1-amine
Canonical SMILES
CC1(CC(CC(C1)(C)N)(C)C)C
InChI
InChI=1S/C11H23N/c1-9(2)6-10(3,4)8-11(5,12)7-9/h6-8,12H2,1-5H3
InChIKey
OGZQTTHDGQBLBT-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
6433106
CAS Number
219810-59-0
DrugBank ID
DB04926
TTD ID
D01KMR

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
N-methyl-D-aspartate receptor (NMDAR) TT9IK2Z NOUNIPROTAC Antagonist [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Emerging analgesics in cancer pain management. Expert Opin Emerg Drugs. 2005 Feb;10(1):151-71.